This paper explores the implications of certain new developments in cell biology upon neuroscience. Until recently it was thought that neurotransmitters and neuromodulators had only one function, which was to stimulate their speci¢c receptors at the cell surface. From here on, all activity was supposed to be e¡ected by postsynaptic cascades. The discovery that membrane components, particularly G-proteinlinked receptors, are not static but are subject to a massive and complex process of continual endocytosis, processing in the endosome system and recycling back to the external membrane, raises the question of its functional signi¢cance. In addition, it has been found that many neuromodulators such as polypeptides have their main locus of action inside the postsynaptic neuron. This review covers the role of the endocytic mechanism on receptor desensitization and resensitization, synaptic reorganization and plasticity, synaptic scaling and the possible repair of oxidative damage. The possible involvement of this system in Alzheimer's disease is discussed.
INTRODUCTION
The classical account of the mode of operation of receptors for neurotransmitters (NT) and neuromodulators (NM) in the nervous system has been a static one. In this account the NT or NM molecule binds to its receptor in the plasma membrane of the neuron. This triggers the opening of an ion channel or the initiation of a postsynaptic cascade in the postsynaptic cell. On leaving the receptor molecule the NT or NM molecule is inactivated by metabolism or transport and the receptor molecule waits in the membrane until the next NTor NM molecule arrives, when the process is repeated. It is recognized that receptor molecules are eventually replaced but it is thought that the time-scale for this is slow. Consequently, the focus of neuroscience research has been on the activity of the receptor and the postsynaptic cascade.
However, recent advances in cell biology have considerably altered this picture. It has been determined in the case of G-protein-linked (and several other) receptors that binding a molecule of the NT or NM results in phosphorylation of the receptor protein. (A list of some of the receptors known to be endocytosed is given in Appendix A.) This leads to a conformational change, which uncovers an amino-acid sequence that acts as a signal for internalization of the receptor (Clague 1998). The receptor is taken up by a pit, usually clathrin coated, sometimes not, which then deepens to form a vesicle (Mukherjee et al. 1997) . The neck of this is pinched o¡ and sealed by a speci¢c proteinödynamin (Bottomley et al. 1999) . This process is very extensiveö some 2000^3000 vesicles per hour can bud o¡ in this manner from the membrane of a cultured cell (Bottomley et al. 1999) . Not only receptors but the entire membrane is also subject to the endocytosis process. A typical membrane protein with a half-life of 10^20 h will make at least ten round trips to the endosome per lifetime (Kelly 1999) .
Upon endocytosis, the vesicle with its contents is traf¢cked to the early endosome and delivers its contents (receptor and in some cases ligand) into the very acidic interior (ca. pH 3.5). This acidity causes the ligand to separate from the receptor protein. From the early endosome, the receptor is moved to the late endosome where a triage process takes place. Some of the protein (possibly normal or repaired) is recycled back to the external membrane. The rest (possibly damaged) goes to the lysosome system where it is broken down (Moore et al. 1999) . The fate of the ligand is known in the case of polypeptide NMs and hormones. These tra¤c to the nucleus to modulate transcription (Koenig & Edwardson 1997) . As the latter say (p. 282)`. . . the purpose of endocytosis is to capture the ligand for subsequent use by the cell'. The fate of smaller ligands is unknown. There exist at present no data on this point. Koenig & Edwardson (1997) express doubts as to whether small molecules with low a¤nity could stick onto their receptors during endocytosis. However, the relationship between internalization and intrinsic activity is nonlinear (Szekeres et al. 1998) .
The process of endocytosis can be relatively fast. Endocytosed b2 adrenergic receptors reach the endosome in 10 min (Cao et al. 1998 ) and dopamine D1 receptors in 4 min (Dumartin et al. 1998) . Endocytosed nerve-growthfactor receptor molecules are completely recycled in 30 min (Zapf-Colby & Olefsky 1998). In the large synaptic terminals of gold¢sh retinal bipolar cells the entire external membrane is recycled every 2 min by an active endocytic cycle (Bretscher & Aguado-Velasco 1998b; Rouze & Schwartz 1998) . Other molecules that play a role in endocytosis include arrestin (Carman & Benovic 1998; Iacovelli et al. 1999) , rabaptin-5 and the growth-associated protein GAP-43 (Neve et al. 1998) , and a special chaperone proteinöreceptor-associated protein (RAP) (Willnow 1998) . A key role in endocytosis is played by phosphatidylinositol-3 kinase (Shpetner et al. 1996; Folli et al. 1997; Chibalin et al. 1998; Krugman & Welch 1998 ). This enzyme is also involved in neurite extension (Kimura et al. 1994) .
THE FUNCTIONAL SIGNIFICANCE OF ENDOCYTOSIS OF RECEPTORS
G-protein-linked receptors are regulated by three processes (Carman & Benovic 1998): (i) desensitization via G-protein-coupled kinases, which phosphorylate activated receptors and recruit arrestin to aid in receptor desensitization; (ii) internalization (endocytosis), which is also facilitated by arrestin; the number of receptor molecules at the surface is a function of the relative weighting of endocytosis and recycling; (iii) reduction in number; this may be absolute or secondary to redistribution to the interior of the cell.
However, endocytosis may have other functions.
(i) The phosphorylated desensitized receptor (and other proteins) cannot be dephosphorylated in situ. This has to be done in the endosome (Ferguson & Caron 1998) . The resensitized dephosphorylated protein is recycled to the surface.
In some cases endocytosis is required for receptor desensitization only (e.g. secretin and conA receptors) and in other cases for resensitization only (e.g. adenosine A2 receptors) (Mundell & Kelly 1998 ). There are also instances where non-clathrin-coated vesicles are involved (e.g. angiotensin and muscarinic acetylcholine receptors) (Vickery & Von Zastrow 1999) .
(ii) The process of membrane recycling can be directed to redistribute membrane components to areas of cellular growth, e.g. growing neurites or new synapses (Hu et al. 1993) . KB cells respond to epidermal growth factor by producing`prodigious' ru¥es in the plasma membrane within minutes (Bretscher & Aguado-Velasco 1998a) . The interior of the ru¥e is formed by actin polymerized by Rac (a Ras-like GTPase). The new surface membrane comes from the endosome by directed recycling of the plasma membrane. Thus, the endosome membrane may act as a`membrane bank' for the external membrane. This process may also be involved in the very rapid growth of dendritic spines (Engert & Bonhoe¡er 1999) , during which large quantities of membrane have to be supplied for the new spine, although there is as yet no direct evidence for this. (iii) All receptor (and other membrane) proteins and lipids are subject to continual oxidative attack by reactive oxygen species produced by a number of enzymes in the cell. This damage needs to be repaired. It had previously been assumed that this was done by repair enzymes in situ in the membrane. However, it is possible that this repair may be e¡ected in the endosome^lysosome system. The ubiquitin^proteosome mechanism is involved in this process (Levkowitz et al. 1999) . Ubiquitin is a 76-amino-acid polypeptide that binds to proteins to be degraded. Its targets include oxidatively damaged proteins (Figueiredo-Pereira & Cohen 1999) and it is involved in degradation of membrane proteins (Kornitzer & Ciechanover 2000) . The ubiquitinp rotein complex is formed in the endosome system, where it is then recognized by the 26S-proteasome enzyme (a large multicatalytic protease), and is degraded in the lysosome system. Grune & Davies (1997) con¢rm that proteosomes are concerned with the removal of oxidized proteins, which plays an essential role in the cellular defence against oxidative attack.
ENDOCYTOSIS IN NEURONS
The soma and dendrites of neurons have extensive networks of tubular early endosomes. Axons have these only in terminals and in boutons-en-passage. Late endosomes predominate in the cell body. These structures are visibly highly mobile (Parton et al. 1992) .
Dendritic spines contain coated vesicles and multivesicular bodies suggesting local endocytic activity (Spacek & Harris 1997 ; and see Harris 1999) . Turrigiano & Nelson (1998) have introduced the concept of`synaptic scaling'. In this the change in rate and ratio between rates of insertion of (RS)-¬-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid (AMPA) receptors into and removal from the synaptic membrane by endocytosis and recycling results in modulation of synaptic strength at all or many of a neuron's synapses. There is direct evidence that AMPA receptors are cycled through an N-ethylmaleimide-sensitive fusion protein (NSF)-dependent pathway (Lledo et al. 1999; Nishimune et al. 1998; Noel et al. 1999; Lissin et al. 1999; Lu« thi et al. 1999; Morales & Goda 1999) . This needs concomitant activation of N-methyl-D-aspartate receptors . In cortical neurons synaptic scaling is modulated (inter alia) by brain-derived neurotrophic factor. Also endocytosis (via PI-3 kinase) is involved in neurite elongation (Kimura et al. 1994) . There is a negative feedback between membrane tension and the endocytosis rate that operates in cells (e.g. during mitosis) (Raucher & Sheetz 1999) .
De Wit et al. (2000) have reported that hydrogen peroxide (a freely di¡usible molecule produced by several neuronal enzymes including cyclo-oxygenase and nitric acid synthase in the glutamate postsynaptic site) inhibits endocytosis of the epidermal-growth-factor receptor in human ¢broblasts at an early stage that involves monoubiquitation of the receptor protein. This provides further evidence that the control of endocytosis, and thus synaptic plasticity, may be mediated in part by redox mechanisms involving hydrogen peroxide as a retrograde messenger (Smythies 1997 (Smythies , 1999 .
In Alzheimer's disease, in which the brain is under severe oxidative stress from the oxidant b-amyloid protein, there is a 2.5-fold increase in the total endosome volume in cortical neurons suggesting increased endocytic activity (Cataldo et al. 1996 (Cataldo et al. , 1997 . Endosomes are the site of internalization of amyloid precursor protein (and probably of b -amyloid formation) and of apolipoprotein E, both relevant to Alzheimer's disease. Physiological levels of the toxic oxidant b-amyloid protein stimulate PI-3 kinase activity (Luo et al. 1996) . This increased rate of endocytosis in Alzheimer's disease may be in response to the b -amyloid protein load, or to the need to repair the oxidatively damaged proteins in the brain, or both.
Furthermore, the neuro¢brillary tangles typical of the disease contain insoluble hyperphosphorylated t protein (Mesulam 1999) . This may be secondary to a primary disorder in the dephosphorylating mechanism of the early endosome (Smythies 2000) .
IMPLICATIONS FOR PHARMACOLOGY
The endocytosis-recycling system for receptors clearly plays a key role in receptor function and in synaptic plasticity and so o¡ers a new venue for the site of action of known, and as yet unknown, drugs. For example, chlorpromazine acts on endosomes by inducing a redistribution of a clathrin-coated pit component AP-2 (Subtil et al. 1994) . It also reduces transferrin but not interleukin-2 endocytosis and powerfully inhibits actin polymerization, and alters cell shape and motility in lymphocytes (Milzani & Dalledonne 1999) . The action of many central nervous system (CNS)-active drugs is currently attributed entirely to their e¡ects on receptors. An additional mode of action may be through the mechanisms described in this review whereby these receptors are endocytosed, processed and recycled. Some preliminary work has been reported in this area. Sojakka et al. (1999) found that isoproterenol inhibits transport from early to late endosomes and causes fragmentation of the late endosome. Henkel et al. (1999) report that substrates for and inhibitors of the intracellular enzyme Kex2 can be delivered by endocytosis. They suggest that this method might be of therapeutic use in the treatment of virus infections that depend on these proteases.
APPENDIX A
Among the receptors relevant to CNS function that are known to be endocytosed are the following (this list is not exclusive): muscarinic ACh (Bernard et al. 1998; Sorensen et al. 1998; Szekeres et al. 1998 ); a-and b-adrenergic (Cao et al. 1998; Hirasawa et al. 1998; Laporte et al. 1999) ; dopamine (Dumartin et al. 1998) ; serotonin (Hu et al. 1993) ; A3 adenosine (Ferguson & Palmer 1999) ; opioid (Ignatova et al. 1999; McConalogue et al. 1999) ; receptors for various polypeptides and proteins (including hormones, growth factors and cytokines) (Grimes et al. 1996; Koenig & Edwardson 1997; Jans & Hassan 1998; Petrou & Tashjian 1998) ; insulin (Di Guglielmo et al. 1998) ; epidermal growth factor (Vieira et al. 1996; Skarpen et al. 1998) ; nerve growth factor and TrkA (Grimes et al. 1996) ; transferrin (Spiro et al. 1996) ; IL-2 (Subtil et al. 1994) ; polymeric IgA2 (Gibson et al. 1998) ; AMPA receptors (Morales & Goda 1999; Carroll et al. 1999) ; metabotropic glutamate (Doherty et al. 1999) ; rabies virus (Lewis & Lentz 1999) ; Na + /K + -ATPase (Chibalin et al. 1998) ; Na + /H + exchanger (Kurashima et al. 1998) .
Note added in proof. Whistler et al. (1999) have found that addictive opiates di¡er from equally e¡ective opiates with low addiction potential in that the latter are endocytosed after they bind to the m receptor whereas the former are not. The authors suggest that this ¢nding indicates`a fundamental revision of our understanding of the role of receptor endocytosis in the biology of opiate drug action and addiction' (Whistler et al. 1999, p.745 ).
